Fulgent Genetics, Inc. (FRA:7F0)

Fulgent Genetics Statistics

Total Valuation

FRA:7F0 has a market cap or net worth of EUR 758.37 million. The enterprise value is 83.35 million.

Market Cap	758.37M
Enterprise Value	83.35M

Important Dates

The next estimated earnings date is Friday, February 27, 2026.

Earnings Date	Feb 27, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	30.91M
Shares Outstanding	n/a
Shares Change (YoY)	+2.27%
Shares Change (QoQ)	+0.67%
Owned by Insiders (%)	33.18%
Owned by Institutions (%)	56.43%
Float	20.66M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	2.82
PB Ratio	0.79
P/TBV Ratio	0.92
P/FCF Ratio	n/a
P/OCF Ratio	584.24
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-2.28
EV / Sales	0.31
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-4.93

Financial Position

The company has a current ratio of 7.01, with a Debt / Equity ratio of 0.01.

Current Ratio	7.01
Quick Ratio	6.28
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	-0.40
Interest Coverage	-1,203.26

Financial Efficiency

Return on equity (ROE) is -3.92% and return on invested capital (ROIC) is -3.90%.

Return on Equity (ROE)	-3.92%
Return on Assets (ROA)	-3.62%
Return on Invested Capital (ROIC)	-3.90%
Return on Capital Employed (ROCE)	-6.22%
Revenue Per Employee	204,830
Profits Per Employee	-27,901
Employee Count	1,313
Asset Turnover	0.26
Inventory Turnover	n/a

Taxes

Income Tax	-3.94M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +51.77% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+51.77%
50-Day Moving Average	21.18
200-Day Moving Average	17.99
Relative Strength Index (RSI)	70.23
Average Volume (20 Days)	18

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	6.78

Income Statement

In the last 12 months, FRA:7F0 had revenue of EUR 268.94 million and -36.63 million in losses. Loss per share was -1.20.

Revenue	268.94M
Gross Profit	110.92M
Operating Income	-60.51M
Pretax Income	-41.59M
Net Income	-36.63M
EBITDA	-39.88M
EBIT	-60.51M
Loss Per Share	-1.20

Balance Sheet

The company has 320.30 million in cash and 6.81 million in debt, giving a net cash position of 664.44 million.

Cash & Cash Equivalents	320.30M
Total Debt	6.81M
Net Cash	664.44M
Net Cash Per Share	n/a
Equity (Book Value)	955.22M
Book Value Per Share	31.10
Working Capital	370.71M

Cash Flow

In the last 12 months, operating cash flow was 1.30 million and capital expenditures -18.22 million, giving a free cash flow of -16.92 million.

Operating Cash Flow	1.30M
Capital Expenditures	-18.22M
Free Cash Flow	-16.92M
FCF Per Share	n/a

Margins

Gross margin is 41.24%, with operating and profit margins of -22.50% and -13.62%.

Gross Margin	41.24%
Operating Margin	-22.50%
Pretax Margin	-15.46%
Profit Margin	-13.62%
EBITDA Margin	-14.83%
EBIT Margin	-22.50%
FCF Margin	n/a

Dividends & Yields

FRA:7F0 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-2.27%
Shareholder Yield	-2.27%
Earnings Yield	-4.83%
FCF Yield	-2.23%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

FRA:7F0 has an Altman Z-Score of 4.89 and a Piotroski F-Score of 6.

Altman Z-Score	4.89
Piotroski F-Score	6